Identifying Treatments for Stage C2 Heart Failure

Clyde W. Yancy, Adrian F. Hernandez, Gregg C. Fonarow*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)34-35
Number of pages2
JournalJAMA cardiology
Volume7
Issue number1
DOIs
StatePublished - Jan 2022

Funding

having a spouse who is employed by Abbott Laboratories outside the submitted work. Dr Hernandez reported receiving grants from American Regent, Boehringer Ingelheim, Merck & Co, and Verily Life Sciences and personal fees from Amgen, AstraZeneca, Bayer, Boston Scientific, and Cytokinetics outside the submitted work. Dr Fonarow reported receiving personal fees from Abbott Laboratories, Amgen, AstraZeneca, Bayer, Cytokinetics, Janssen Pharmaceuticals, Medtronic, Merck & Co, and Novartis outside the submitted work. No other disclosures were reported.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this